We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.68% | 1.515 | 1.48 | 1.55 | 1.50 | 1.48 | 1.50 | 3,138,617 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.23 | 16.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2022 08:29 | Looking very soggy here this morning.........is it something that MadVlad said??.......or not said? | badger60 | |
21/2/2022 21:09 | Secondly.......anon y mouse...a dangerous uberbull on LSE.....beware!...an ........"As stated from the CEO they are fully funded to clinical trials and the PreIND will not slow down the application. These announcements were made through the correct channels. I think there are announcements in the next couple of weeks, things turn quickly and despite the de-rampers best efforts i'm feeling confident." | badger60 | |
21/2/2022 12:47 | Looks like a bit of short covering......until the next leg down....... | badger60 | |
21/2/2022 12:20 | Not looking good for Vlad's pie in the sky CAR-T effort........ By the time Vlad gets around to having his preIND looked at, patients will be getting inexpensive CART treatment off the shelf..... | badger60 | |
21/2/2022 12:08 | Looking more and more like the mm's are getting worried about where the next wad of Hemocasino cash is going to come from. I can't see them wanting to hold/trade shares in a company which is unable to raise cash........and ergo goes bust......... | badger60 | |
21/2/2022 11:55 | Catsan With all due respect mate it’s not about saving lives it’s about making money, and until HEMO say something tangible regarding their product candidates holders will continue to suffer. Badger is right that this is an extremely high risk sector, if they make it into clinical trials we’ll make money and if they don’t we will lose money. NOTHING said is personal to the company and you’ll find nobody has any moral values when posting. Weigh up the potential upside along with the potential downside along with the long timeframe of pharma. Ignore ALL posts and decide what is best for you financially. | lunus1 | |
21/2/2022 11:34 | CatsanNice guy though you are, unfortunately you are much too innocent and naive to be playing in the stock markets..... especially in very high risk shares like this. My advice to you is sell up and put your money into a Building Society. | badger60 | |
21/2/2022 11:27 | Good morning, I have to say I am very unhappy by the way people are saying untruths about Hemo. I have been careful to only take my research from to avoid being led astray and I do not see why people are so against hemogenyx. They are trying to do good works and save lives, being treated like this is just not nice. | catsan | |
21/2/2022 11:21 | You and your little bunch are trading this well today on small volumes Badger. Hope you’re making enough to justify your time and effort. Nothing a small player like me can do about your shenanigans apart from wait for news. You may force the weak out but not me. | lunus1 | |
21/2/2022 10:38 | Seems like the mkt is giving MadVlad another thumbs down........ | badger60 | |
21/2/2022 08:49 | You don't get much right Dave, including "Lunus"......... | badger60 | |
21/2/2022 07:29 | I know who I trust! Appreciate your input Lunas. | david gruen | |
21/2/2022 03:09 | Hi Lunus, good to hear from you and glad that you're still keeping your misplaced faith in Hemocasino. I disagree that you should just look at now, and hoping forward without taking into account what has happened when looking back (ouch!). The past history of Hemocasino (4.5 years of ineptitude) represents the foundation on what it has been built, and gauges what's very likely to happen going forward............. I do not see the very precarious future of Hemocasino through the same rose tinted glasses as you do, but rather the total opposite. Anyway I'm glad to be keeping you amused while you are awaiting news, even though if and when it arrives it probably will not be what you want to hear.......good luck anyway. | badger60 | |
20/2/2022 19:45 | Well you’ve been your usual busy and amusing self of late Badger, certainly keeps me occupied whilst awaiting news. As regards my ‘early days’ comment, I never look back on the past and focus on the here and now. So, it’s early days in my opinion as I believe, as I’ve consistently said of late, that June is the time to evaluate where HEMO are. The PIND statement is of no concern to me. In essence it will be done in the background, no meeting will be held and the IND application will be submitted as planned.It will imo be approved, probably fast tracked, and clinical trials will commence probably early Q3. I’m happy to wait for clinical proof of concept to be achieved later this year. CDX is also running in parallel for IND submission and there’s a CBR announcement based on 2 years work to come also. Your mate Walts, far from being on holiday, will be working on further funding (non dilutive) and announce in before he departs in June so a lot to look forward to over the next 12-14 weeks. By the way, they are funded until clinical proof of concept whether you agree or not, so let’s just wait and see who rises most in 12 weeks, Delt or HEMO. One of us will look a total wsnker with his predictions so have some patience and see which one of us it is. I’ll certainly take it on the chin if it’s me..I hope you will if it’s you. Stay calm, deep breaths, relax and wait:) | lunus1 | |
20/2/2022 19:43 | Well you’ve been your usual busy and amusing self of late Badger, certainly keeps me occupied whilst awaiting news. As regards my ‘early days’ comment, I never look back on the past and focus on the here and now. So, it’s early days in my opinion as I believe, as I’ve consistently said of late, that June is the time to evaluate where HEMO are. The PIND statement is of no concern to me. In essence it will be done in the background, no meeting will be held and the IND application will be submitted as planned.It will imo be approved, probably fast tracked, and clinical trials will commence probably early Q3. I’m happy to wait for clinical proof of concept to be achieved later this year. CDX is also running in parallel for IND submission and there’s a CBR announcement based on 2 years work to come also. Your mate Walts, far from being on holiday, will be working on further funding (non dilutive) and announce in before he departs in June so a lot to look forward to over the next 12-14 weeks. By the way, they are funded until clinical proof of concept whether you agree or not, so let’s just wait and see who rises most in 12 weeks, Delt or HEMO. One of us will look a total wsnker with his predictions so have some patience and see which one of us it is. I’ll certainly take it on the chin if it’s me..I hope you will if it’s you. Stay calm, deep breaths, relax and wait:) | lunus1 | |
20/2/2022 12:29 | KEEP SHORTING GUYS!! LET HEMO DELIST | marcus80 | |
20/2/2022 12:29 | WE CAN DO THIS GUYS !! SHORT LIKE A KING AND VLAD WILL LOSE HIS COMPANY! WE ARE ON THE RIGHT TRACK ! KEEP PUSHING !! KEEP SHORTING !! | marcus80 | |
20/2/2022 12:28 | BADGER FOR PRESIDENT | marcus80 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions